ID

40944

Descripción

The primary focus of this first time in human (FTIH) study was to evaluate the safety and tolerability of GSK1292263 and to estimate GSK1292263 pharmacokinetic (PK) parameters and pharmacodynamic (PD) effects in healthy volunteers. Subject: FTIH, oral, safety, tolerability, pharmacokinetics, glucose, pharmacodynamics, male, female, gastric emptying Indication Studied: Type 2 Diabetes Mellitus Study ID: 111596 Clinical Study ID: 111596 Study Title: A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00783549 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK1292263, Sitagliptin Trade Name: N/A Study Indication: Dyslipidaemias

Palabras clave

Versiones (2)
  1. 21/4/20 21/4/20 -
  2. 7/6/20 7/6/20 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

7 de junio de 2020

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin

Inglés

Logs and repeats Logs/Repeats 1

1 formularios  
Date of visit/assessment
Descripción

Date of visit/assessment

Alias
UMLS CUI-1
C1320303
UMLS CUI-2
C2985720
Date of visit/assessment
Descripción

Date is the start of the study for this subject

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1320303
UMLS CUI [1,2]
C2985720
Adverse event/concomitant medication/repeat assessment check questions
Descripción

Adverse event/concomitant medication/repeat assessment check questions

Alias
UMLS CUI-1
C0877248
UMLS CUI-2
C2347852
UMLS CUI-3
C0205341
UMLS CUI-4
C0220825
Were any concomitant medications taken by the subject during the study?
Descripción

concomitant medications

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0681850
UMLS CUI [1,4]
C0347984
UMLS CUI [1,5]
C0008972
Did the subject experience any non-serious adverse events during the study?
Descripción

non-serious adverse events

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0681850
UMLS CUI [1,3]
C0347984
UMLS CUI [1,4]
C0008972
Did the subject experience any serious adverse events during the study?
Descripción

serious adverse events

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0681850
UMLS CUI [1,3]
C0347984
UMLS CUI [1,4]
C0008972
Were any abnormal, clinically significant ECG measurements recorded for this subject during the study?
Descripción

abnormal ECG measurements

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C0347984
UMLS CUI [1,3]
C0008972
UMLS CUI [1,4]
C1832603
UMLS CUI [1,5]
C2985739
Were any repeat haematology, clinical chemistry or urinalysis samples taken?
Descripción

repeat haematology, clinical chemistry or urinalysis samples

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0008000
UMLS CUI [1,2]
C0200345
UMLS CUI [1,3]
C0205341
UMLS CUI [2,1]
C0018941
UMLS CUI [2,2]
C0200345
UMLS CUI [2,3]
C0205341
UMLS CUI [3,1]
C0042014
UMLS CUI [3,2]
C0200345
UMLS CUI [3,3]
C0205341
Were any repeat ECGs performed?
Descripción

repeat ECGs

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0013798
UMLS CUI [1,2]
C0205341
Were any repeat vital signs recorded?
Descripción

repeat vital signs

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0518766
UMLS CUI [1,2]
C0205341
Were any repeat PK blood samples taken?
Descripción

PK: pharmacokinetic

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1277698
UMLS CUI [1,2]
C0031327
UMLS CUI [1,3]
C0205341
Were any repeat PD samples taken?
Descripción

PD: Pharmacodynamic

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0205341
UMLS CUI [1,2]
C0851347
UMLS CUI [1,3]
C0200345
Volver a la parte superior de la página

Similar models

Logs and repeats Logs/Repeats 1

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Date of visit/assessment
C1320303 (UMLS CUI-1)
C2985720 (UMLS CUI-2)
Date of visit/assessment
Item
Date of visit/assessment
date
C1320303 (UMLS CUI [1,1])
C2985720 (UMLS CUI [1,2])
Item Group
Adverse event/concomitant medication/repeat assessment check questions
C0877248 (UMLS CUI-1)
C2347852 (UMLS CUI-2)
C0205341 (UMLS CUI-3)
C0220825 (UMLS CUI-4)
Item
Were any concomitant medications taken by the subject during the study?
integer
C2347852 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0681850 (UMLS CUI [1,3])
C0347984 (UMLS CUI [1,4])
C0008972 (UMLS CUI [1,5])
concomitant medications
Code List
Were any concomitant medications taken by the subject during the study?
CL Item
Yes (1)
CL Item
No (2)
Item
Did the subject experience any non-serious adverse events during the study?
integer
C1518404 (UMLS CUI [1,1])
C0681850 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0008972 (UMLS CUI [1,4])
non-serious adverse events
Code List
Did the subject experience any non-serious adverse events during the study?
CL Item
Yes (1)
CL Item
No (2)
Item
Did the subject experience any serious adverse events during the study?
integer
C1519255 (UMLS CUI [1,1])
C0681850 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0008972 (UMLS CUI [1,4])
serious adverse events
Code List
Did the subject experience any serious adverse events during the study?
CL Item
Yes (1)
CL Item
No (2)
Item
Were any abnormal, clinically significant ECG measurements recorded for this subject during the study?
integer
C0681850 (UMLS CUI [1,1])
C0347984 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
C1832603 (UMLS CUI [1,4])
C2985739 (UMLS CUI [1,5])
abnormal ECG measurements
Code List
Were any abnormal, clinically significant ECG measurements recorded for this subject during the study?
CL Item
Yes (1)
CL Item
No (2)
Item
Were any repeat haematology, clinical chemistry or urinalysis samples taken?
integer
C0008000 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
C0205341 (UMLS CUI [1,3])
C0018941 (UMLS CUI [2,1])
C0200345 (UMLS CUI [2,2])
C0205341 (UMLS CUI [2,3])
C0042014 (UMLS CUI [3,1])
C0200345 (UMLS CUI [3,2])
C0205341 (UMLS CUI [3,3])
repeat haematology, clinical chemistry or urinalysis samples
Code List
Were any repeat haematology, clinical chemistry or urinalysis samples taken?
CL Item
Yes (1)
CL Item
No (2)
Item
Were any repeat ECGs performed?
integer
C0013798 (UMLS CUI [1,1])
C0205341 (UMLS CUI [1,2])
repeat ECGs
Code List
Were any repeat ECGs performed?
CL Item
Yes (1)
CL Item
No (2)
Item
Were any repeat vital signs recorded?
integer
C0518766 (UMLS CUI [1,1])
C0205341 (UMLS CUI [1,2])
concomitant medications
Code List
Were any repeat vital signs recorded?
CL Item
Yes (1)
CL Item
No (2)
Item
Were any repeat PK blood samples taken?
integer
C1277698 (UMLS CUI [1,1])
C0031327 (UMLS CUI [1,2])
C0205341 (UMLS CUI [1,3])
concomitant medications
Code List
Were any repeat PK blood samples taken?
CL Item
Yes (1)
CL Item
No (2)
Item
Were any repeat PD samples taken?
integer
C0205341 (UMLS CUI [1,1])
C0851347 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,3])
concomitant medications
Code List
Were any repeat PD samples taken?
CL Item
Yes (1)
CL Item
No (2)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial